GGrantIndex
← Leaderboards

Tian-Li Wang

Johns Hopkins University

$3,014,402
Attributed
$4,608,849
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $718K · FY201125
$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,608,849 · 4

By mechanism

R01$3,796,803 · 2
P50$424,461 · 1
R21$387,585 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasm Of Ovary

Research focus

Malignant Neoplasm Of OvaryTumorWomanMalignant NeoplasmsTissuesNeoplastic CellTumor ProgressionCancer BiologyCollaborationsComplexSamplingBaseOperative Surgical ProceduresCancer TypeCarcinomaTrainingResearch PersonnelDiagnosisHigh RiskSerousTravelLaboratoriesMouse ModelMediating

Grant awards (14)

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women$417,626
R01 · FY2025 · CA
Developmental Research Program$300,356
P50 · FY2025 · CA · contact PI
Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women$406,959
R01 · FY2024 · CA
Developmental Research Program$124,105
P50 · FY2024 · CA · contact PI
Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women$423,593
R01 · FY2023 · CA
Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women$433,937
R01 · FY2022 · CA
Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women$443,815
R01 · FY2021 · CA
Characterizing Notch3 Signaling in Ovarian Cancer$340,300
R01 · FY2015 · CA · contact PI
TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA$176,175
R21 · FY2015 · CA · contact PI
Characterizing Notch3 Signaling in Ovarian Cancer$330,091
R01 · FY2014 · CA · contact PI
TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA$211,410
R21 · FY2014 · CA · contact PI
Characterizing Notch3 Signaling in Ovarian Cancer$319,882
R01 · FY2013 · CA · contact PI
Characterizing Notch3 Signaling in Ovarian Cancer$340,300
R01 · FY2012 · CA · contact PI
Characterizing Notch3 Signaling in Ovarian Cancer$340,300
R01 · FY2011 · CA · contact PI